Abstract
Small molecule receptors are attractive potential sensors of post-translational modifications, including methylated lysine and methylated arginine. Using dynamic combinatorial chemistry (DCC), our lab previously identified a suite of receptors that bind to Kme3 with a range of affinities ranging from low micromolar to high nanomolar, each with a unique selectivity for Kme3 over the lower methylation states. To enable these receptors to have broad application as Kme3 sensors, we have developed a method for their late-stage modification, which we used to synthesize biotinylated derivatives of A2B, A2D, and A2G in a single step. For our most attractive receptor for applications, A2N, we needed to develop an alternative method for its selective functionalization, which we achieved by “activating” the carboxylic acids on the constituent monomer A or N by pre-functionalizing them with glycine (Gly). Using the resulting Gly-A and Gly-N monomers, we synthesized the novel A2N variants A2Gly-N, Gly-A2N, and Gly-A2Gly-N, which enabled the late stage biotinylation of A2N wherever Gly was incorporated. Finally, we performed ITC and NMR binding experiments to study the effect that carboxylate spacing has on the affinity and selectivity of A2Gly-N and Gly-A2N for KmeX guests compared to A2N. These studies revealed the proximity of the carboxylates to play a complex role in the molecular recognition event, despite their positioning on the outside of the receptor.
Graphical Abstract

Approaches for the late-stage modification of receptors discovered from dynamic combinatorial libraries and the investigation of the effects of simple modifications on receptor binding and selectivity.
Introduction
Since the hypothesis of the histone code by Strahl and Allis at the turn of the 21st century,1 significant progress has been made toward understanding the complex machinery that enables the reading, writing, and erasing of histone post-translational modifications (PTMs) and the associated consequences for gene expression.2–10 While the majority of advancements can be attributed to significant advances in antibody and mass spectrometry (MS) approaches,11–15 we and others envisioned that synthetic receptors could offer several advantages for the study of PTMs, particularly methylated lysine (Lys) and arginine (Arg).16–24 Although generally weaker binders than antibodies, synthetic receptors are typically simple and inexpensive to produce, they have well understood molecular structure and they offer complete batch-to-batch reliability. Already, an assortment of applications has been reported using synthetic receptors to study PTMs, some of which are only possible due to their unique properties compared to antibodies.21–24 As the applications of synthetic receptors for studying PTMs continue to advance, these tools may enable new approaches for understanding PTMs, which may allow questions to be answered that remain difficult to address using the current tools available.
Utilizing dynamic combinatorial chemistry (DCC),25–27 our lab has discovered a number of receptors with varied affinity and selectivity for Kme3 over the lower Lys methylation states (Figure 1), with binding affinities ranging from the low micromolar to high nanomolar range, as well as the first reported receptor for asymmetric dimethylarginine (aRMe2).16–19
Figure 1.
Receptors identified from our lab using dynamic combinatorial chemistry that bind selectively to trimethyllysine or asymmetric dimethylarginine.
To be applicable as probes for Kme3 sensing, it is necessary to functionalize these receptors with a tag that enables readout of Kme3 binding. This could be achieved directly by the attachment of a reporter molecule (e.g. fluorescent dye), or indirectly through the attachment of a recognition motif such as biotin, which is commonly used as an affinity tag due to its picomolar affinity to the proteins avidin and streptavidin. Herein, we report a method that enables the rapid mono-functionalization of A2B, A2D, and A2G, which we demonstrate for the synthesis of biotinylated derivatives of each receptor (Figure 2). This method relies on the reduced reactivity of the carboxylic acids on monomer A using standard amide coupling reagents, enabling the selective modification of monomers B, D, and G in the assembled receptors.
Figure 2.
Approach for mono-functionalization of A2B, A2D, and A2G with Biotin-PEG-NH2. Conditions: R-NH2 = 7.5 eq. (PEG11) or 10 eq. (PEG2); DIC = 5 eq. (PEG11) or 7.5 eq. (PEG2); NHS: 5 eq. (PEG11) or 7.5 eq. (PEG2); DIPEA = 10 eq. (PEG11) or 12 eq. (PEG2). Yields provided are estimated from peak area of crude HPLC traces.
Because the carboxylates on monomer N are similar to those on monomer A, A2N cannot be directly functionalized in the same manner. Instead, we also developed a method to pre-functionalize the carboxylic acids on monomers A and N, which we utilized to distance the carboxylates from the ethanoanthracene bridge using glycine (Gly). Using the modified monomers, Gly-A and Gly-N, in combination with unmodified A and N, we show that the novel receptors A2Gly-N, Gly-A2N, and Gly-A2Gly-N can all be accessed using dynamic combinatorial libraries (DCLs). These derivatives enable selective downstream modification of only the Gly-spaced monomers in assembled receptors, as the Gly carboxylates are reactive using the method for the mono-functionalization of A2B, A2D, and A2G. Using this approach, we demonstrate the di-biotinylation of A2N using A2Gly-N. Lastly, using the Gly-functionalized derivatives of A2N, we investigated the role of the proximity of the charge for guest binding using isothermal titration calorimetry (ITC) and NMR.
Results and Discussion
Mono-Functionalization of Receptors
The modification of A2B, A2D, and A2G was achieved using standard amide coupling conditions, using diisopropylcarbodiimide (DIC), N-hydroxysuccinimide (NHS) and diisopropylethylamine (DIPEA). The coupling is carried out in anhydrous DMF for 48 hours, after which the solvent is removed and the modified receptors are purified by reverse phase HPLC (Figure 2). Using this method, biotinylated derivatives of each receptor were synthesized using a short polyethylene glycol (PEG) diamine linker (Biotin-PEG2-NH2). Using a 10-fold excess of this linker, A2B-Biotin, A2D-Biotin, and A2G-Biotin were prepared in approximately 46%, 13%, and 17% yield in a single step, using RP-HPLC to isolate the modified receptors (see SI, yields estimated from HPLC peak areas). The poorer yields observed for A2D and A2G can likely be attributed to greater steric constraint of the carboxylates due to their position ortho to a disulfide instead of meta, as in A2B. Although biotin could be pre-attached to monomers B, D, and G, and these modified monomers used to assemble the modified receptors in DCLs, late stage functionalization of the purified receptors enables potentially any marker of interest to be conjugated to the receptor in a single step. In addition to being convenient, this method enables expensive reagents such as fluorophores to be conjugated with little waste of reagent. To demonstrate this point, we coupled the commercially available Biotin-PEG11-NH2 reagent to A2B using a 7.5-fold excess of reagent, which cleanly provided A2B-PEG11-Biotin in 60% yield (estimated from HPLC peak area) using the same coupling conditions. Due to the long length and the monodisperse nature of this PEG11 derivative, this reagent is expensive and cannot be synthesized and purified as easily as the PEG2 derivative. Thus, the ability to directly attach it to the receptors in a single step allows a minimal amount of the reagent to be used.
Modification of A2N
Unlike A2B, A2D and A2F, A2N is unreactive under the same DIC coupling conditions. This is not surprising, as the carboxylates on monomers A and N are similar, and monomer A is not modified by DIC. Because A2N binds to Kme3 with the best combination of affinity and selectivity of any receptor we have discovered, we needed an alternative approach for the attachment of biotin that would enable A2N to also have application for Kme3 sensing.
Due to the similarity of the carboxylic acids on A and N, we focused on developing methods to modify the carboxylates of A and N prior to use in DCLs (Figure 3a). We began by protecting the thiols with triphenylmethyl (trityl) protecting groups (Trt-A/N), which are installed by stirring the monomer and two equivalents of triphenylmethanol in 95:5 trifluoroacetic acid (TFA)/dichloromethane (DCM). Our initial attempts at modifying the carboxylates focused on single step couplings using traditional amide coupling reagents. Like others before us,28,29 we observed poor reactivity of the carboxylates on A and N, which has been suggested to be due to steric constraints at the bridging olefin position. Thus, we were surprised to discover that both monomers can easily be converted to their corresponding N-hydroxysuccinimidyl (NHS) esters by coupling NHS using dicyclohexylcarbodiimide (DCC) in DCM (Trt-A/N-OSu). In their activated ester form, A and N can both be coupled to a variety of amines simply by stirring the two components together in DCM.30 If the amine is used as its acid salt, an equivalent of DIPEA is needed for the reaction to occur.
Figure 3.
(a) General synthesis of glycine spaced monomers shown for A, but identical for monomer N. (b) New receptors A2Gly-N, Gly-A2N, and Gly-A2Gly-N synthesized using the Gly-spaced monomers. Using the same coupling conditions previously optimized for A2B, A2D, and A2G, (Biotin-PEG2)2-A2Gly-N was synthesized from A2Gly-N (top).
With the goal of making A2N reactive toward modification after isolation from a DCL, we envisioned that if we simply spaced the carboxylates from the bridgehead position, they would become more reactive under standard coupling conditions. To test this idea, we coupled glycine methyl ester to Trt-A/N-OSu by stirring with four equivalents of the amino acid (as its hydrochloride salt) and four equivalents of DIPEA in DCM. Once coupled, the Trt-A/N-Gly-OMe monomers were deprotected in two steps, starting with the removal of the trityl groups by stirring in 5:95 TFA/DCM with an excess of triisopropylsilane (TIPS) to give Gly-A/N-OMe. The methyl esters were then hydrolyzed using LiOH in H2O to furnish the final Gly-A/N monomers.
Using a combination of the modified Gly-A/N monomers and unmodified monomers, A2Gly-N, Gly-A2N, and Gly-A2Gly-N were all synthesized via preparative DCLs using butyltrimethylammonium iodide (BuNme3+) as a guest template in 50 mM borate buffer (Figure 3b). After five days, the receptors were purified by RP-HPLC, giving combined yields of the three isomers of 40%, 35% and 53% for A2Gly-N, Gly-A2N and Gly-A2Gly-N, respectively (estimated from HPLC peak area). This is similar to the combined yield previously observed for A2N of 45%,18 indicating that the Gly substitutions do not significantly influence the amplification of the receptor under these conditions. Interestingly, the Gly modifications had varied effects on the resolution of the rac-, meso1-, and meso2- isomers of each receptor: A2Gly-N eluted similarly to A2N, with the rac- and meso1- isomers co-eluting first, and the meso2- isomer eluting afterward; all isomers of Gly-A2N nearly co-eluted, making it impossible to isolate a single isomer; and all three of the isomers of Gly-A2Gly-N were well resolved, making it simple to isolate each one individually. As predicted, the Gly spacing enabled Biotin-PEG-NH2 to be coupled using the same coupling conditions described in Figure 2. Using this approach, A2N-Biotin was prepared in a single step from A2Gly-N in 48 % yield (estimated from HPLC peak area). Importantly, this approach allowed the selective modification of monomer N over monomer A.
Binding Studies Using Gly-spaced Receptors
A2N contains a deep aromatic binding pocket that complements the larger, more hydrophobic Kme3 over the lower Lys methylation states (Figure 4) and provides the highest affinity binding as well as the greatest selectivity of the receptors we have developed.18 The six carboxylic acids are necessary for water solubility, but it was unclear what role, if any, their charge played in the binding of the cationic ammoniums inside the aromatic pocket. We previously observed that neighboring Arg and Lys residues could directly affect the affinity and selectivity of A2N for a primary site of Kme3 binding,31 which we attributed to favorable electrostatic interactions between the secondary basic residues and the carboxylates.
Figure 4.

Gas phase minimized model of meso2-A2N binding to Kme3. Monomer A is white, monomer N is blue, and the carboxylates are shown in red.
With the Gly-spaced receptors, we aimed to address the questions regarding (1) the contribution the carboxylates toward binding inside of the pocket (primary interaction) and (2) the importance of their proximity to the binding pocket for secondary interactions with Arg outside of the pocket. This was achieved by comparing the binding interactions of the Gly-spaced derivatives of A2N to model peptide guests using isothermal titration calorimetry (ITC). For comparison to A2N, we used a peptide containing residues 4-12 of the histone 3 (H3) tail and an N-terminal WGGG- tag for concentration determination (Ac-WGGG-QTARKmeXSTG-NH2, X=0-3), which we have used previously to study the affinity and selectivity of A2N for Kme3.18 To study the contribution of neighboring charge to binding, we also studied binding to an equivalent peptide where the neighboring Arg8 is mutated to Gly (Ac-WGGG-QTAGKmeXSTG-NH2, X=3). While A2N and A2Gly-N were used as single (meso2-) isomers in the binding and NMR studies (vide infra), we could not isolate the pure meso2- isomer of Gly-A2N; instead, a mixture of isomers was used composed of predominantly the meso2- isomer.
Comparison of Affinities and Selectivites
With increasing spacing of the carboxylates on A2N, the binding affinity for RKme2 and RKme1 are nearly unaffected, while the affinity for RKme3, RKme0, and GKme3 decreased, regardless of whether the Gly residues were on A or N (Table 1). As a result, A2Gly-N and Gly-A2N are less selective for Kme3 than A2N. Because the higher affinity of A2N for RKme0 over RKme1 was previously proposed to be due to the engagement of a different mode of binding only possible for RKme0,18 the loss in affinity of the Gly-spaced derivatives for this peptide suggests that the spacing changes this mode of binding.
Table 1.
ITC Binding data for A2N, Gly-A2N, and A2Gly-N binding to H3K9meX (Ac-WGGG-QTA[R/G]KmeXSTG-NH2).
| Entry | Receptor | Peptide | Kd
b (μM) |
Selectivity Factor c | ΔG d (kcal/mol) |
|---|---|---|---|---|---|
| 1 | A2Ne | RKme3 | 0.30 ± 0.04 | - | -8.91 ± 0.07 |
| 2 | A2Ne | RKme2 | 4.1 ± 0.5 | 14 | -7.36 ± 0.07 |
| 3 | A2Ne | RKme1 | 40 ± 4 | 131 | -6.01 ± 0.06 |
| 4 | A2Ne | RKme0 | 10.5 ± 0.9 | 35 | -6.80 ± 0.05 |
| 5 | A2Ne | GKme3 | 1.3 ± 0.2 | 4.2 | -8.05 ± 0.08 |
| 6 | A2Gly-Ne | RKme3 | 2.0 ± 0.2 | - | -7.80 ± 0.07 |
| 7 | A2Gly-Ne | RKme2 | 5.3 ± 0.5 | 2.7 | -7.21 ± 0.06 |
| 8 | A2Gly-Ne | RKme1 | 36 ± 4 | 18.3 | -6.08 ± 0.07 |
| 9 | A2Gly-Ne | RKme0 | 34 ± 4 | 17.5 | -6.10 ± 0.06 |
| 10 | A2Gly-Ne | GKme3 | 7 ± 1 | 3.8 | -7.01 ± 0.08 |
| 11 | Gly-A2Nf | RKme3 | 2.7 ± 0.7 | - | -7.6 ± 0.1 |
| 12 | Gly-A2Nf | RKme2 | 5.5 ± 0.7 | 2.0 | -7.19 ± 0.08 |
| 13 | Gly-A2Nf | RKme1 | 40 ± 4 | 14.7 | -6.01 ± 0.06 |
| 14 | Gly-A2Nf | RKme0 | 60 ± 6 | 21.7 | -5.77 ± 0.06 |
| 15 | Gly-A2Nf | GKme3 | 10 ± 1 | 3.6 | -6.84 ± 0.06 |
Conditions: 26 °C in 10 mM borate buffer, pH 8.5.
Errors are from measurements taken in duplicate or triplicate and are estimated at <10%, unless otherwise noted.
Selectivity is calculated as the affinity for Kme3 over the designated methylation state in that row.
Errors are propagated from errors in Kd.
The pure meso2- isomer was used.
A mixture of isomers was used containing predominantly the meso2- isomer.
Comparing the binding of each of the receptors to RKme3, there is a decrease in affinity with the initial introduction of two Gly residues on N to give A2Gly-N (ΔΔG = 1.1 kcal/mol, Table 1, compare entries 6 and 1), while the subsequent introduction of four Gly residues to give Gly-A2N only caused an additional change of 0.2 kcal/mol (ΔΔG = 1.3 kcal/mol, compare entries 11 and 1), which is within error of the value for A2Gly-N. Because the drop in affinity is not proportional to the number of Gly substitutions, this suggests that a similar mechanism may be weakening the binding of both of the modified receptors to Kme3. A mechanism that is consistent with this observation is a conformational change that disfavors binding of the large trimethylammonium of Kme3 inside the aromatic pocket. The binding of Kme and Kme2 may not be affected due to their smaller size, or because they prefer to bind to a different conformation of the receptor in which the NH groups on Kme and Kme2 are still able to hydrogen bond with water. In the case of unmodified RK peptide, we had previously proposed that it binds to the exterior of the receptor.18 Addition of the Gly residues would be expected to influence this mode of binding as well, as is observed (entries 4 vs 9).
Importantly, the data are inconsistent with a through-space electrostatic interaction between the cationic guest and the carboxylates on the exterior of the binding pocket, which was originally proposed by Dougherty in his cyclophane host that consists of two ethenoanthracene units identical to those in monomer A.28 Despite differences in the host geometries and the guests studied, the proximity of the modified carboxylates to the bound guest in both systems is identical. If the carboxylates interact with the bound guest through a long range electrostatic interaction, spacing with Gly would be expected to weaken this interaction equally for all cationic guests binding to the A2N derivatives, but this is clearly not the case. Further studies are necessary to more fully understand the contribution of such long range interactions in molecular recognition.
As previous studies have shown that the neighboring Arg contributes to binding through interaction with the carboxylates and aromatic rings on the outside of the receptor, we investigated whether spacing of the carboxylates weakens this interaction. We find that for all three receptors, the interaction with Arg provides about 0.8 kcal/mol to the interaction energy (compare entries 1 and 5, 6 and 10, and 11 and 15). While this lack of dependence on spacing could suggest the interaction with Arg is unaffected, it may also be due to the fact that not all the carboxylates in A2Gly-N and Gly-A2N contain the Gly spacer.
NMR Binding Studies
We also compared the binding properties of A2Gly-N, Gly-A2N, and A2N to Kme3 by comparing the upfield shifting induced by each receptor on the simple guest butyl trimethylammonium (BuNme3+, Table 2) under saturating conditions. For this model guest, binding to A2N causes approximately the same upfield shifting of the Nme3 protons (2.41 ppm) as was previously observed for the equivalent protons on the peptide guest Ac-Kme3G-NH2 (2.46 ppm).18 This indicates that BuNme3+ is suitable for modelling binding to Kme3. Using the same concentrations of A2N, A2Gly-N and Gly-A2N (again, as a mixture of isomers), less upfield shifting and more significant broadening of the Nme3+ protons of the guest were observed with increasing Gly incorporation (Figure S35). Due to the differences in affinities of each of these receptors for Kme3 (Table 1), the changes in upfield shifting may partially reflect a different proportion of bound guest in each spectrum, although this would be expected to cause proportional differences in upfield shifting for all affected protons. Instead, the differences in upfield shifting are more significant for the Nme3 and γ-methylene protons compared to the more distant α- and β-methylene protons, suggesting that the guest engages in weaker cation-pi interactions with the Gly-substituted receptors, perhaps due to the inability to access the preferred conformation for optimal binding, as suggested above.
Table 2.
Change in chemical shifts (Δδ) observed for BuNme3+ when bound to A2N, A2Gly-N, and Gly-A2N. The analogous Δδ values previously observed for the peptide guest Ac-Kme3G-NH2 when bound to A2N are included for reference.18
| Receptor: | A2Na | A2Nb | A2Gly-Nb | Gly-A2Nb,c | |
|---|---|---|---|---|---|
| Guest: | Ac-Kme3G-NH2 | BuNme3+ | BuNme3+ | BuNme3+ | |
| Δδ (ppm): | Nme3 | -2.46 | -2.41 | -2.32 | -1.99 |
| δ | -3.45 | - | - | - | |
| γ | -3.25 | -2.93 | -2.80 | -2.54 | |
| β | -2.09 | -1.40 | -1.34 | -1.31 | |
| α | -0.60 | -0.47 | -0.46 | -0.49 | |
Conditions: 10 mM borate buffered D2O (pH 8.67).
Conditions: 10 mM borate buffered D2O (pH 8.5)
Used as a mixture of isomers containing predominantly meso2-Gly-A2N.
Conclusions
In conclusion, we have developed a straightforward method for the late stage modification of the receptors A2B, A2D, and A2G. Using this method, we demonstrated the facile synthesis of biotinylated derivatives of each receptor containing a short PEG linker, as well as the synthesis of a biotinylated derivative of A2B with a PEG11 linker using the commercially available Biotin-PEG11-NH2. This simple method should enable the attachment of nearly any desired functionality to these receptors, which will enable their rapid application to new directions in the field of PTM sensing, which we are actively pursuing. Further, as DCC continues to be a valuable tool for the discovery of new receptors with unique affinities and selectivities for different PTMs, we expect that these methods will continue to have value in modifying novel receptors that share the A2X framework.
We have also developed a simple new method for the modification of monomers A and N, which have until this point proven challenging targets for functionalization.28,29 Using this method, we showed that we could di-functionalize each monomer with Gly to yield Gly-A and Gly-N, which were used in DCLs to assemble the novel receptors A2Gly-N, Gly-A2N, and Gly-A2Gly-N. As only the Gly-spaced monomer is reactive under the coupling conditions developed for A2B, A2D and A2G, we were able to demonstrate the selective functionalization of N in a similar manner by coupling Biotin-PEG2-NH2 to A2Gly-N to form A2N-Biotin. Although not included here, this approach also enables monomer A to be activated for functionalization using the same conditions in any A2X receptor, enabling the single step pan-functionalization of all carboxylates.
Finally, we used ITC to study the effect of spacing the carboxylates on A and N using Gly on the binding properties of A2Gly-N and Gly-A2N for KmeX compared to A2N. Although these carboxylates cannot interact directly with a guest bound in the aromatic pocket due to their positioning on the outside of the receptor, their modification with Gly reduced the affinity of the modified receptors for Kme3 from high nanomolar for A2N to low micromolar for A2Gly-N and Gly-A2N. We believe that the Gly-spacing causes a conformational change in the receptors that affects binding to the larger trimethylammonium, consistent with NMR studies that indicate less optimal guest binding with A2Gly-N and Gly-A2N. Overall, these studies reveal that synthetic modification of these receptors can influence binding properties, but that they still maintain affinities and selectivities in the useful range in this case. The methods developed here enable new approaches toward the late stage modification of complex macrocyclic receptors discovered from DCLs, and should facilitate the rapid development of new applications for these unique receptors.
Experimental
Detailed synthetic procedures for the modification of the receptors, as well as the preparation of Gly-A and Gly-N can be found in the SI. Biotin-PEG2-NH2 has been prepared previously and was synthesized according to published literature procedures, although this compound is also commercially available. Biotin-PEG11-NH2 was purchased from Quanta Biodesign. A2B, A2D, and A2G were prepared in preparative DCLs as described previously, and were purified by reverse-phase HPLC using gradients between NH4OAc buffered solvents (A: 10 mM NH4OAc in H2O; B: 10 mM NH4OAc in 9:1 ACN:H2O) on an Atlantis PrepT3 5 μm 10 × 150 mm C18 column.
A2Gly-N, Gly-A2N, and Gly-A2Gly-N were prepared on a preparative scale by dissolving the corresponding monomers (concentrations can be found in the SI) in 50 mM borate buffer (pH 8.5) with 10 mM butyltrimethylammonium iodide (BuNme3+) as a template. After 5 days, the receptors were purified by RP-HPLC using a gradient of 0-100% B in 45 minutes (A: 10 mM NH4OAc in H2O; B: 10 mM NH4OAc in 9:1 ACN:H2O) on an Atlantis PrepT3 5 μm 10 × 150 mm C18 column. After isolation, the receptors were lyophilized for 5-7 days to remove any trace NH4OAc salts. The concentration of the receptors was determined using the same extinction coefficient determined for A2N previously, 11,665 M-1cm-1.
All NMR experiments were performed using a Bruker 400 MHz or Bruker 600 MHz instrument, as noted. Data analysis was performed using Topspin 3.1 software. VT 1D NMRs and NMR binding experiments were collected on a Bruker 600 MHz insturment in 10 mM borate buffererd D2O (pH 8.67). Proton assignments in the binding studies were made using TOCSY analysis. High resolution mass spectrometry was performed on a Thermo LTQ-FT-ICR mass spectrometer.
Peptides were synthesized on a Tetras Peptide Synthesizer using CLEAR-Amide resin from Peptides International. Peptides were purified by RP-HPLC using Waters X-Bridge C18 columns and gradients between water (A) and acetonitrile (B) containing 0.01% trifluoroacetic acid. They were desalted by RP-HPLC using NH4OAc buffered solvents on an Atlantis PrepT3 5 μm 10 × 100 mm C18 column, and were lyophilized for 5-7 days to remove all volatile salts
All ITC titrations were performed using a MicroCal Auto-iTC200 at 26 °C. Data analysis was performed using the built in Origin 7 software using a one site binding model. Unless otherwise noted, titrations were performed in duplicate. A 10 mM pH 8.5 sodium borate buffer was used for all experiments. All concentrations were determined using a NanoDrop2000 with a xenon flash lamp, 2048 element linear silicon CCD array detector, and 1 mm path length. ∼1.1-2.4 mM solutions of peptide were titrated into ∼100-180 μM solutions of receptor using 2 μL injections every 3 minutes. Heats of dilution of peptides were subtracted prior to analysis in Origin.
Supplementary Material
Acknowledgments
We gratefully acknowledge funding from the W. M. Keck foundation for this work. This material is based in part upon work supported by the National Science Foundation under Grant No. CHE-1306977 and also the National Science Foundation Graduate Research Fellowship to N.K.P. under grant no. DGE-1144081. A.P. was supported by the Biophysical Society's Short Course in Biophysics, funded by the NIH (Grant #2T36GM075791-06).
Footnotes
Electronic Supplementary Information (ESI) available: Detailed synthetic procedures; NMR characterization; Hi-Res Mass Spec; Receptor characterization; ITC binding data. See DOI: 10.1039/b000000x/
Notes and References
- 1.Strahl BD, Allis CD. Nature. 2000;403:41–45. doi: 10.1038/47412. [DOI] [PubMed] [Google Scholar]
- 2.Richards EJ, Elgin SCR. Cell. 2002;108:489–500. doi: 10.1016/s0092-8674(02)00644-x. [DOI] [PubMed] [Google Scholar]
- 3.Khorasanizadeh S. Cell. 2004;116:259–272. doi: 10.1016/s0092-8674(04)00044-3. [DOI] [PubMed] [Google Scholar]
- 4.Martin C, Zhang Y. Nat Rev Mol Cell Biol. 2005;6:838–849. doi: 10.1038/nrm1761. [DOI] [PubMed] [Google Scholar]
- 5.Kouzarides T. Cell. 2007;128:693–705. doi: 10.1016/j.cell.2007.02.005. [DOI] [PubMed] [Google Scholar]
- 6.Taverna SD, Li H, Ruthenburg AJ, Allis CD, Patel DJ. Nat Struct Mol Biol. 2007;14:1025–1040. doi: 10.1038/nsmb1338. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.Li B, Carey M, Workman JL. Cell. 2007;128:707–719. doi: 10.1016/j.cell.2007.01.015. [DOI] [PubMed] [Google Scholar]
- 8.Jones PA, Baylin SB. Cell. 2007;128:683–692. doi: 10.1016/j.cell.2007.01.029. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9.Bannister AJ, Kouzarides T. Cell Res. 2011;21:381–395. doi: 10.1038/cr.2011.22. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10.Rothbart SB, Strahl BD. Biochim Biophys Acta - Gene Regul Mech. 2014;1839:627–643. doi: 10.1016/j.bbagrm.2014.03.001. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11.Schones DE, Zhao K. Nat Rev Genet. 2008;9:179–191. doi: 10.1038/nrg2270. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12.Zhao Y, Jensen ON. Proteomics. 2009;9:4632–4641. doi: 10.1002/pmic.200900398. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13.Chatterjee C, Muir TW. J Biol Chem. 2010;285:11045–11050. doi: 10.1074/jbc.R109.080291. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14.Britton LMP, Gonzales-Cope M, Zee BM, Garcia BA. Expert Rev Proteomics. 2011;8:631–643. doi: 10.1586/epr.11.47. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15.Huang H, Lin S, Garcia Ba, Zhao Y. Chem Rev. 2015 doi: 10.1021/cr500491u. 150217145638004. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16.Ingerman LA, Cuellar ME, Waters ML. Chem Commun. 2010;46:1839–1841. doi: 10.1039/c000255k. [DOI] [PubMed] [Google Scholar]
- 17.James LI, Beaver JE, Rice NW, Waters ML. J Am Chem Soc. 2013;135:6450–6455. doi: 10.1021/ja307907p. [DOI] [PubMed] [Google Scholar]
- 18.Pinkin NK, Waters ML. Org Biomol Chem. 2014;12:7059–67. doi: 10.1039/c4ob01249f. [DOI] [PubMed] [Google Scholar]
- 19.Beaver JE, Peacor BC, Bain JV, James LI, Waters ML. Org Biomol Chem. 2015;13:3220–3226. doi: 10.1039/c4ob02231a. [DOI] [PubMed] [Google Scholar]
- 20.Beshara CS, Jones CE, Daze KD, Lilgert BJ, Hof F. ChemBioChem. 2010;11:63–66. doi: 10.1002/cbic.200900633. [DOI] [PubMed] [Google Scholar]
- 21.Minaker SA, Daze KD, Ma MCF, Hof F. J Am Chem Soc. 2012:11674–11680. doi: 10.1021/ja303465x. [DOI] [PubMed] [Google Scholar]
- 22.Daze KD, Pinter T, Beshara CS, Ibraheem A, Minaker SA, Ma MCF, Courtemanche RJM, Campbell RE, Hof F. Chem Sci. 2012;3:2695–2699. [Google Scholar]
- 23.Allen HF, Daze KD, Shimbo T, Lai A, Musselman CA, Sims JK, Wade PA, Hof F, Kutateladze TG. Biochem J. 2014;459:505–512. doi: 10.1042/BJ20140145. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24.Florea M, Kudithipudi S, Rei A, Gonzalez-Alvarez MJ, Jeltsch A, Nau WM. Chem A Eur J. 2012:3521–3528. doi: 10.1002/chem.201103397. [DOI] [PubMed] [Google Scholar]
- 25.Corbett PT, Leclaire J, Vial L, West KR, Wietor JL, Sanders JKM, Otto S. Chem Rev. 2006;106:3652–3711. doi: 10.1021/cr020452p. [DOI] [PubMed] [Google Scholar]
- 26.Otto S, Furlan RLE, Sanders JKM. Science. 2002;297:590–593. doi: 10.1126/science.1072361. [DOI] [PubMed] [Google Scholar]
- 27.Corbett PT, Sanders JKM, Otto S. Chemistry. 2008;14:2153–2166. doi: 10.1002/chem.200701413. [DOI] [PubMed] [Google Scholar]
- 28.Ngola SM, Kearney PC, Mecozzi S, Russell K, Dougherty Da. J Am Chem Soc. 1999;121:1192–1201. [Google Scholar]
- 29.Marquis R, Kulikiewicz K, Lebedkin S, Kappes MM, Meunier CMS, Wagner A. Chem - A Eur J. 2009;15:11187–11196. doi: 10.1002/chem.200901545. [DOI] [PubMed] [Google Scholar]
- 30.Pinkin NK. PhD Thesis. University of North Carolina; Chapel Hill: 2015. [Google Scholar]
- 31.Pinkin NK, Liu I, Abron JD, Waters ML. Chem Eur J. 2015 doi: 10.1002/chem.201502302. Accepted. [DOI] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.



